Cargando…
Outcomes after primary and repeat thermal ablation of hepatocellular carcinoma with or without liver transplantation
OBJECTIVES: Thermal ablation (TA) is an established treatment for early HCC. There is a lack of data on the efficacy of repeated TA for recurrent HCC, resulting in uncertainty whether good oncologic outcomes can be obtained without performing orthotopic liver transplantation (OLTx). This study analy...
Autores principales: | , , , , |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Springer Berlin Heidelberg
2022
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9123025/ https://www.ncbi.nlm.nih.gov/pubmed/35133486 http://dx.doi.org/10.1007/s00330-021-08515-3 |
_version_ | 1784711473960845312 |
---|---|
author | Serbanescu-Kele Apor de Zalán, Christiaan M. C. Ruiter, Simeon J. S. van den Berg, Aad P. Pennings, Jan Pieter de Jong, Koert P. |
author_facet | Serbanescu-Kele Apor de Zalán, Christiaan M. C. Ruiter, Simeon J. S. van den Berg, Aad P. Pennings, Jan Pieter de Jong, Koert P. |
author_sort | Serbanescu-Kele Apor de Zalán, Christiaan M. C. |
collection | PubMed |
description | OBJECTIVES: Thermal ablation (TA) is an established treatment for early HCC. There is a lack of data on the efficacy of repeated TA for recurrent HCC, resulting in uncertainty whether good oncologic outcomes can be obtained without performing orthotopic liver transplantation (OLTx). This study analyses outcomes after TA, with a special focus on repeat TA for recurrent HCC, either as a stand-alone therapy, or in relationship with OLTx. METHODS: Data from a prospectively registered database on interventions for HCC in a tertiary hepatobiliary centre was completed with follow-up until December 2020. Outcomes studied were rate of recurrence after primary TA and after its repeat interventions, the occurrence of untreatable recurrence, OS and DSS after primary and repeat TA, and complications after TA. In cohorts matched for confounders, OSS and DSS were compared after TA with and without the intention to perform OLTx. RESULTS: After TA, 100 patients (56·8%) developed recurrent HCC, of whom 76 (76·0%) underwent up to four repeat interventions. During follow-up, 76·7% of patients never developed a recurrence unamenable to repeat TA or OLTx. OS was comparable after primary TA and repeat TA. In matched cohorts, OS and DSS were comparable after TA with and without the intention to perform OLTx. CONCLUSIONS: We found TA to be an effective and repeatable therapy for primary and recurrent HCC. Most recurrences can be treated with curative intent. There are patients who do well with TA alone without ever undergoing OLTx. KEY POINTS: • Recurrent HCC after primary TA can often be treated effectively with repeat TA. Survival after repeat TA is comparable to primary TA. • In matched cohorts, outcomes after TA with and without subsequent waitlisting for OLTx are comparable. • There are patients who do well for many years with primary and repeat TA alone; some despite multiple recurrences. SUPPLEMENTARY INFORMATION: The online version contains supplementary material available at 10.1007/s00330-021-08515-3. |
format | Online Article Text |
id | pubmed-9123025 |
institution | National Center for Biotechnology Information |
language | English |
publishDate | 2022 |
publisher | Springer Berlin Heidelberg |
record_format | MEDLINE/PubMed |
spelling | pubmed-91230252022-05-22 Outcomes after primary and repeat thermal ablation of hepatocellular carcinoma with or without liver transplantation Serbanescu-Kele Apor de Zalán, Christiaan M. C. Ruiter, Simeon J. S. van den Berg, Aad P. Pennings, Jan Pieter de Jong, Koert P. Eur Radiol Interventional OBJECTIVES: Thermal ablation (TA) is an established treatment for early HCC. There is a lack of data on the efficacy of repeated TA for recurrent HCC, resulting in uncertainty whether good oncologic outcomes can be obtained without performing orthotopic liver transplantation (OLTx). This study analyses outcomes after TA, with a special focus on repeat TA for recurrent HCC, either as a stand-alone therapy, or in relationship with OLTx. METHODS: Data from a prospectively registered database on interventions for HCC in a tertiary hepatobiliary centre was completed with follow-up until December 2020. Outcomes studied were rate of recurrence after primary TA and after its repeat interventions, the occurrence of untreatable recurrence, OS and DSS after primary and repeat TA, and complications after TA. In cohorts matched for confounders, OSS and DSS were compared after TA with and without the intention to perform OLTx. RESULTS: After TA, 100 patients (56·8%) developed recurrent HCC, of whom 76 (76·0%) underwent up to four repeat interventions. During follow-up, 76·7% of patients never developed a recurrence unamenable to repeat TA or OLTx. OS was comparable after primary TA and repeat TA. In matched cohorts, OS and DSS were comparable after TA with and without the intention to perform OLTx. CONCLUSIONS: We found TA to be an effective and repeatable therapy for primary and recurrent HCC. Most recurrences can be treated with curative intent. There are patients who do well with TA alone without ever undergoing OLTx. KEY POINTS: • Recurrent HCC after primary TA can often be treated effectively with repeat TA. Survival after repeat TA is comparable to primary TA. • In matched cohorts, outcomes after TA with and without subsequent waitlisting for OLTx are comparable. • There are patients who do well for many years with primary and repeat TA alone; some despite multiple recurrences. SUPPLEMENTARY INFORMATION: The online version contains supplementary material available at 10.1007/s00330-021-08515-3. Springer Berlin Heidelberg 2022-02-08 2022 /pmc/articles/PMC9123025/ /pubmed/35133486 http://dx.doi.org/10.1007/s00330-021-08515-3 Text en © The Author(s) 2022 https://creativecommons.org/licenses/by/4.0/Open AccessThis article is licensed under a Creative Commons Attribution 4.0 International License, which permits use, sharing, adaptation, distribution and reproduction in any medium or format, as long as you give appropriate credit to the original author(s) and the source, provide a link to the Creative Commons licence, and indicate if changes were made. The images or other third party material in this article are included in the article's Creative Commons licence, unless indicated otherwise in a credit line to the material. If material is not included in the article's Creative Commons licence and your intended use is not permitted by statutory regulation or exceeds the permitted use, you will need to obtain permission directly from the copyright holder. To view a copy of this licence, visit http://creativecommons.org/licenses/by/4.0/ (https://creativecommons.org/licenses/by/4.0/) . |
spellingShingle | Interventional Serbanescu-Kele Apor de Zalán, Christiaan M. C. Ruiter, Simeon J. S. van den Berg, Aad P. Pennings, Jan Pieter de Jong, Koert P. Outcomes after primary and repeat thermal ablation of hepatocellular carcinoma with or without liver transplantation |
title | Outcomes after primary and repeat thermal ablation of hepatocellular carcinoma with or without liver transplantation |
title_full | Outcomes after primary and repeat thermal ablation of hepatocellular carcinoma with or without liver transplantation |
title_fullStr | Outcomes after primary and repeat thermal ablation of hepatocellular carcinoma with or without liver transplantation |
title_full_unstemmed | Outcomes after primary and repeat thermal ablation of hepatocellular carcinoma with or without liver transplantation |
title_short | Outcomes after primary and repeat thermal ablation of hepatocellular carcinoma with or without liver transplantation |
title_sort | outcomes after primary and repeat thermal ablation of hepatocellular carcinoma with or without liver transplantation |
topic | Interventional |
url | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9123025/ https://www.ncbi.nlm.nih.gov/pubmed/35133486 http://dx.doi.org/10.1007/s00330-021-08515-3 |
work_keys_str_mv | AT serbanescukeleapordezalanchristiaanmc outcomesafterprimaryandrepeatthermalablationofhepatocellularcarcinomawithorwithoutlivertransplantation AT ruitersimeonjs outcomesafterprimaryandrepeatthermalablationofhepatocellularcarcinomawithorwithoutlivertransplantation AT vandenbergaadp outcomesafterprimaryandrepeatthermalablationofhepatocellularcarcinomawithorwithoutlivertransplantation AT penningsjanpieter outcomesafterprimaryandrepeatthermalablationofhepatocellularcarcinomawithorwithoutlivertransplantation AT dejongkoertp outcomesafterprimaryandrepeatthermalablationofhepatocellularcarcinomawithorwithoutlivertransplantation |